✦ LIBER ✦

L-DOPA treatment from the viewpoint of neuroprotection

✍ Scribed by Norio Ogawa; Masato Asanuma; Ikuko Miyazaki; Francisco J. Diaz-Corrales; Ko Miyoshi

Book ID: 106093171
Publisher: Springer
Year: 2005
Tongue: English
Weight: 373 KB
Volume: 252
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-005-4006-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa therapy from the neuroprotectio

Levodopa therapy from the neuroprotection viewpoint

✍ Tomoyoshi Kondo 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 220 KB

Mechanisms and treatment of L-DOPA-induc

Mechanisms and treatment of L-DOPA-induced dyskinesias – Introduction

✍ W. Danysz 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 22 KB

Sulphate Conjugation and L-Dopa Treatmen

Sulphate Conjugation and L-Dopa Treatment of Parkinsonian Patients

✍ RUTLEDGE, CHARLES O.; HOEHN, MARGARET M. 📂 Article 📅 1973 🏛 Nature Publishing Group 🌐 English ⚖ 451 KB

Amantadine attenuates response alteratio

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

✍ M. Karcz-Kubicha; G. Quack; W. Danysz 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 153 KB

Different responsiveness of striatonigra

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment

✍ A. R. Carta; E. Tronci; A. Pinna; M. Morelli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Comparative study of selegiline plus L-d

Comparative study of selegiline plus L-dopa–carbidopa versus L-dopa–carbidopa alone in the treatment of parkinson's disease

✍ Timothy Brannan; Dr. Melvin D. Yahr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o